![Otis Brawley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Otis Brawley
Directeur/Membre du Conseil chez
PDS BIOTECHNOLOGY CORPORATION
Fortune : 3 M $ au 31/05/2026
Profil
Otis W.
Brawley is currently an Independent Director at Incyte Corp., Agilent Technologies, Inc., PDS Biotechnology Corp., and Lyell Immunopharma, Inc. since 2020 or 2021.
Dr. Brawley is a Professor of Oncology & Epidemiology at The Johns Hopkins University since 2019.
Dr. Brawley is a Member of the Scientific Counselors at the National Cancer Institute, a Trustee at The Jackson Laboratory, and a Member of the National Academy of Medicine (United States).
Formerly, Dr. Brawley was Director at Theragenics Corp.
from 1995 to 2008, Director at Georgia Cancer Center from 2002 to 2007, Director at The National Coalition For Cancer Research, Chief Medical & Scientific Officer at American Cancer Society, Inc. from 2007 to 2018, and Professor at Emory University School of Medicine from 2001 to 2018.
Education includes undergraduate studies at The University of Chicago and a doctorate from Pritzker School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/03/2026 | 13 874 ( 0 % ) | 2 M $ | 31/05/2026 | |
INCYTE CORPORATION 0,01 % | 08/06/2026 | 12 894 ( 0,01 % ) | 1 M $ | 31/05/2026 |
LYELL IMMUNOPHARMA, INC. 0,01 % | 10/06/2026 | 1 782 ( 0,01 % ) | 30 882 $ | 31/05/2026 |
| 12/01/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Otis Brawley
| Sociétés | Poste | Début |
|---|---|---|
| PDS BIOTECHNOLOGY CORPORATION | Directeur/Membre du Conseil | 03/11/2020 |
| LYELL IMMUNOPHARMA, INC. | Directeur/Membre du Conseil | 01/04/2021 |
| INCYTE CORPORATION | Directeur/Membre du Conseil | 27/09/2021 |
| AGILENT TECHNOLOGIES, INC. | Directeur/Membre du Conseil | 17/11/2021 |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2019 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
The Jackson Laboratory
 The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Directeur/Membre du Conseil | - |
Anciens postes connus de Otis Brawley
| Sociétés | Poste | Fin |
|---|---|---|
American Cancer Society, Inc.
 American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Directeur Technique/Scientifique/R&D | 01/12/2018 |
| ░░░░░ ░░░░░░░░░░ ░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░ ░░░░░░░░░ ░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Otis Brawley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
73
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Incyte Corp.
 Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
Theragenics Corp.
 Theragenics Corp. Medical SpecialtiesHealth Technology Develops and manufactures radioisotopes and brachytherapy seeds | Health Technology |
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous Conducts research projects & awards grants for cancer research | Miscellaneous |
American Cancer Society, Inc.
American Cancer Society, Inc. Miscellaneous Commercial ServicesCommercial Services Operates voluntary health organization for cancer research | Commercial Services |
The Jackson Laboratory
The Jackson Laboratory BiotechnologyHealth Technology Operates as a nonprofit biomedical research institution | Health Technology |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
Pritzker School of Medicine
 Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emory University School of Medicine
 Emory University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgia Cancer Center | |
PDS Biotechnology Corp.
 PDS Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Develops clinical-stage immunotherapies to treat various early-stage and late-stage cancers which includes head & neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer and related cancers | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
The National Coalition For Cancer Research |
